Reforgene Medicine

Reforgene Medicine is a leading pioneer in the field of gene-editing therapeutics, headquartered in China. Our core competency lies in leveraging state-of-the-art CRISPR and genomic technologies to catalyze the development of novel, transformative medicines. Our technological acumen spans an extensive range of capabilities, from the innovation of proprietary gene-editing platforms to drug discovery pipelines, from the establishment of unique in vivo and in vitro preclinical models to comprehensive pharmacokinetic and safety profiling. Guided by our mission to harness innovative gene-editing modalities for the development of accessible and curative therapies, we have constructed a robust pipeline that addresses unmet medical needs across various therapeutic areas including genetic disorders, complex diseases, and oncology.